EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ganoderic Acid Ameliorates Ulcerative Colitis by Improving Intestinal Barrier Function via Gut Microbiota Modulation

Yuwei Ye, Abudumijiti Abulizi, Yukun Zhang, Feng Lu, Yongpan An iD, Chaoqun Ren, Hang Zhang, Yiming Wang, Dongmei Lin, Dan Lu, Min Li iD, Baoxue Yang iD

International Journal of Molecular Sciences · 10.03.2025 · 26 (6) · 2466

DOI: 10.3390/ijms26062466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.03.2025. Verfasst von Yuwei Ye und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vascular Homeostasis and Remodeling, Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Ulcerative, Triterpenes, Intestinal Mucosa. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China grants, Beijing Natural Science Foundation grant, The grant from the non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic and recurrent gastrointestinal disease that affects millions of humans worldwide and imposes a huge social and economic burden. It is necessary to find safe and efficient drugs for preventing and treating UC. The aim of this study was to determine whether ganoderic acid (GA), the main bioactive components of Ganoderma lucidum, has preventive and therapeutic effect on UC in a dextran sulfate sodium (DSS)-induced UC mouse model. Our experimental results showed that GA significantly ameliorated the body weight loss and disease activity index (DAI) of UC mice. GA significantly restored 11% of the colon length and 69% of the spleen index compared to UC mice. GA significantly decreased the intestinal inflammatory response and improved the barrier function of the intestine by upregulating the tight junction proteins Zonula occludens-1 (ZO-1), occludin and claudin-1. A co-housing experiment showed that gut microbiota accounted for the therapeutic activity of GA on UC, which was confirmed by fecal microbiota transplantation from GA-treated mice to the UC mice. Furthermore, 16S rDNA high-throughput sequencing of fecal bacteria showed that GA significantly enriched the abundance of Lactobacillus, Oscillospira, Odoribacter and Ruminococcus, which were positively correlated with colon length. Furthermore, this study found the functional metabolites, including Indole-3-acetaldehyde (IAAld), Glutamine (Gln) and Glutathione (GSH), reduced barrier damage in the Caco-2 cell model. In conclusion, this study suggests that GA could ameliorate UC by improving intestinal barrier function via modulating gut microbiota and associated metabolites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColitis, UlcerativeTriterpenesIntestinal MucosaAnimalsMiceDisease Models, AnimalDextran SulfateHumansMaleClaudin-1Fecal Microbiota TransplantationZonula Occludens-1 ProteinOccludinMice, Inbred C57BLCaco-2 CellsColonIntestinal Barrier Function

Stichwörter der Autor:innen

ganoderic acidgut microbiotaintestinal barrier functiontight junctionulcerative colitis

Substanzen

Triterpenesganoderic acidDextran SulfateClaudin-1Zonula Occludens-1 ProteinOccludin

Autor:innen und Institutionen

  • State Key Laboratory of Vascular Homeostasis and Remodeling, Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
  • JUNCAO Technology Research Institute, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
  • Institute of Systems Biomedicine, Department of Pathology, School of Basic Medical Sciences, Peking University, Beijing 100191, China.

ORCID-Profile: Yongpan An, Min Li, Baoxue Yang

Förderung

  • National Natural Science Foundation of China grants
  • Beijing Natural Science Foundation grant
  • The grant from the non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
  • National Natural Science Foundation of China
  • Proof of Concept Project of Medical Innovation Center (Taizhou) of Peking University

Zitieren

APA

Ye, Y., Abulizi, A., Zhang, Y., Lu, F., An, Y., Ren, C., Zhang, H., Wang, Y., Lin, D., Lu, D., Li, M., & Yang, B. (2025). Ganoderic Acid Ameliorates Ulcerative Colitis by Improving Intestinal Barrier Function via Gut Microbiota Modulation. International Journal of Molecular Sciences, 26(6), 2466. https://doi.org/10.3390/ijms26062466

Vancouver

Ye Y, Abulizi A, Zhang Y, Lu F, An Y, Ren C, et al. Ganoderic Acid Ameliorates Ulcerative Colitis by Improving Intestinal Barrier Function via Gut Microbiota Modulation. International Journal of Molecular Sciences. 2025;26(6):2466. doi:10.3390/ijms26062466

BibTeX
@article{Ye2025,
  author = {Ye, Yuwei and Abulizi, Abudumijiti and Zhang, Yukun and Lu, Feng and An, Yongpan and Ren, Chaoqun and Zhang, Hang and Wang, Yiming and Lin, Dongmei and Lu, Dan and Li, Min and Yang, Baoxue},
  title = {Ganoderic Acid Ameliorates Ulcerative Colitis by Improving Intestinal Barrier Function via Gut Microbiota Modulation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {6},
  pages = {2466},
  doi = {10.3390/ijms26062466}
}
Kostenlos starten →